Retatrutide-Induced Intractable Diarrhea
Abstract
Gastrointestinal symptoms accompanying the use of glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide receptor-GLP-1 receptor co-agonists have been extensively catalogued. This case report contains a dramatic presentation of unintended consequences from the use of a novel triple-hormone receptor agonist and points toward the need for increased regulatory measures regarding the marketing of these treatments.
Fields of Study & Subjects
Microscopic Colitis
Celiac Disease Research and Management
Potassium and Related Disorders
Publication details
- Journal / source
- Annals of Internal Medicine Clinical Cases
- Publisher
- American College of Physicians
- Volume
- 5
- Issue
- 4
- Publication date
- 1 April 2026
- Language
- EN